QT Vascular – an overlooked potential health care play?

In one of the articles by Channelnewsasia dated 18 Dec 2014, it was reported that the general healthcare sector has performed well this year and prospects likely remain bright next year. The healthcare index, as measured by the SGX Healthcare Index, registered a year to date return of approximately 9-10% vs the 2% from STI. Factors such as the aging demographics and rising demand for quality healthcare etc. continue to bode well for the overall healthcare sector. One of the stocks which has underperformed on a year to date basis is QT Vascular. Average analyst target is $0.665. Its price chart seems to be in the […]

Hi-P – a proxy to Apple and Xiaomi?

Hi-P recently caught my attention as it has been conducting several share buybacks in the past one month. Secondly, Hi-P’s chart formed a bullish double bottom formation with the breakout of the neckline at $0.690 on 24 Nov. Thirdly, Apple’s (Hi-P’s customer) market capitalisation hit US$700b on 25 Nov 2014 on optimism over iPhone 6 sales and new Apple products. Fourthly, an article dated 7 Nov 2014 on Financial Times reportedly cited that Xiaomi (Hi-P’s customer) is seeking to raise US$1.5 billion in new capital at a valuation set to exceed US$40 billion.  The above factors prompted me to take a closer look into Hi-P. Description of […]